Skip to the page

Data / Drug companies / Amorepacific Corporation

Amorepacific Corporation: 93 products in the FDA NDC directory, labeler code 43419

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Amorepacific Corporation (labeler code 43419) lists 93 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 93 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 1, 2026.

The request: Watch Amorepacific Corporation (FDA labeler code 43419): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
43419
Products in commercial distribution
93
Packages
93
Finished drugs by generic name
9
Prescription products
0
Over the counter products
93
Flagged as original packager
23 of 23 products that carry the flag
Started marketing in the last 12 months
79
Products with a marketing end date set
4
Earliest marketing start
December 5, 2012
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs93100%

Products by type

TypeProductsShare
Over the counter drugs93100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Titanium dioxide4051
Octinoxate, titanium dioxide, and zinc oxide204
Octinoxate1910
Octinoxate, titanium dioxide, and homosalate71
Zinc oxide, octinoxate, and titanium dioxide31
Homosalate, octinoxate,octisalate, and titanium dioxide11
Avobenzone, homosalate, octisalate, octocrylene cream11
Octocrylene, homosalate, octisalate, avobenzone117
Homosalate, octocrylene, octisalate, avobenzone126

Dosage forms

Dosage formProductsShare
Lotion9096.8%
Cream33.2%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Hera black cushion foundation 50n143419-278LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 48n143419-277LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 47n143419-276LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 45w143419-275LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 43o143419-274LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 43n143419-273LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 41w143419-272LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 39n143419-271LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 37w143419-270LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 35n143419-269LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 35c143419-268LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 32w143419-267LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 31n143419-266LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 31c143419-265LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 29w143419-264LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 29n143419-263LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 28o143419-262LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 28n143419-261LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 28c143419-260LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 26w143419-251LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 26n143419-250LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 22n143419-249LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 22n143419-248LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 22n143419-247LotionOver the counter monograph drugsSeptember 1, 2026
Hera black cushion foundation 21w143419-246LotionOver the counter monograph drugsSeptember 1, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.